Gracia Martínez

1.7k total citations
28 papers, 226 citations indexed

About

Gracia Martínez is a scholar working on Hematology, Molecular Biology and Oncology. According to data from OpenAlex, Gracia Martínez has authored 28 papers receiving a total of 226 indexed citations (citations by other indexed papers that have themselves been cited), including 24 papers in Hematology, 7 papers in Molecular Biology and 7 papers in Oncology. Recurrent topics in Gracia Martínez's work include Multiple Myeloma Research and Treatments (22 papers), Protein Degradation and Inhibitors (6 papers) and Myeloproliferative Neoplasms: Diagnosis and Treatment (4 papers). Gracia Martínez is often cited by papers focused on Multiple Myeloma Research and Treatments (22 papers), Protein Degradation and Inhibitors (6 papers) and Myeloproliferative Neoplasms: Diagnosis and Treatment (4 papers). Gracia Martínez collaborates with scholars based in Brazil, Spain and United Kingdom. Gracia Martínez's co-authors include Inmaculada Castillo, F. Sáez-Royuela, Alberto Moreno, Juan Carlos Porres, Vicente Carréño, Camila C.G. Linardi, Durvanei Augusto Maria, Estela Maria Novak, Ricardo Rodrigues Giorgi and Martin Metzger and has published in prestigious journals such as Journal of Clinical Oncology, Blood and Hepatology.

In The Last Decade

Gracia Martínez

22 papers receiving 220 citations

Peers

Gracia Martínez

HEMAT

HEPAT

EPIDE

ONCOL

Vincenzo Mettivier Italy

Kyoya Kumagai Japan

Ally Speight United Kingdom

Man Fai Law China

Alexandre Aubourg France

NE Traub United Kingdom

Emna Gouider Tunisia

Vincenzo Cassibba Italy

Catherine Dong France

Mélanie Mercier France

Vincenzo Mettivier Italy

Gracia Martínez

115 ×1.1

HEMAT

70 ×0.8

HEPAT

58 ×0.7

EPIDE

57 ×0.8

ONCOL

36 ×0.6

Citations per year, relative to Gracia Martínez Gracia Martínez (= 1×) peers Vincenzo Mettivier

Countries citing papers authored by Gracia Martínez

Since Specialization

Citations

This map shows the geographic impact of Gracia Martínez's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Gracia Martínez with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Gracia Martínez more than expected).

Fields of papers citing papers by Gracia Martínez

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Gracia Martínez. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Gracia Martínez. The network helps show where Gracia Martínez may publish in the future.

Co-authorship network of co-authors of Gracia Martínez

This figure shows the co-authorship network connecting the top 25 collaborators of Gracia Martínez. A scholar is included among the top collaborators of Gracia Martínez based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Gracia Martínez. Gracia Martínez is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Hungria, Vânia, Edvan Crusoé, Michel Eid Farah, et al.. (2025). Practical Guidance on the Clinical Management of Ocular Adverse Events Associated with Belantamab Mafodotin for Patients with Relapsed/Refractory Multiple Myeloma: Latin American Expert Panel Recommendations. Oncology and Therapy. 13(3). 797–810.

Hungria, Vânia, et al.. (2024). Brazilian Real-Life Experience of Multiple Myeloma (MMyBRAve): Improvement in Outcomes, But Remaining Diagnostic and Therapeutic Gaps. Clinical Lymphoma Myeloma & Leukemia. 25(1). 26–31. 1 indexed citations

Carvalho, Noêmia Barbosa, Vera Lúcia Teixeira de Freitas, Giancarlo Fatobene, et al.. (2024). Multiple myeloma and Chagas disease: qPCR as a marker for preemptive antiparasitic therapy: a case reports series and review. Revista do Instituto de Medicina Tropical de São Paulo. 66. e10–e10. 2 indexed citations

Fatobene, Giancarlo, et al.. (2022). Evaluation of Disease Progression/Relapse in Patients with Multiple Myeloma Waiting for Autologous Hematopoietic Cell Transplant from a Resource-Constrained Country. Transplantation and Cellular Therapy. 28(3). S72–S72.

Fernandes, Fábio, Angelina Maria Martins Lino, Leonardo Oliveira Mendonça, et al.. (2022). Systemic amyloidosis journey from diagnosis to outcomes: a twelve-year real-world experience of a single center in a middle-income country. Orphanet Journal of Rare Diseases. 17(1). 425–425. 6 indexed citations

Maiolino, Ângelo, Edvan de Queiroz Crusoé, Gracia Martínez, et al.. (2022). Guidelines on the diagnosis and management of multiple myeloma treatment: Associação Brasileira de Hematologia e Hemoterapia e Terapia Celular Project guidelines: Associação Médica Brasileira – 2022. Part I. Hematology Transfusion and Cell Therapy. 44(3). 410–418. 1 indexed citations

Martínez, Gracia, et al.. (2021). Anaplastic multiple myeloma with amplification of the IGH-CCND1 gene fusion. Hematology Transfusion and Cell Therapy. 45(4). 495–498. 1 indexed citations

Villar, Rosângela Correa, et al.. (2021). Safety and Feasibility Analysis of a Prospective Trial on Stereotactic Body Radiotherapy for Solitary Bone Plasmacytoma. Acta Haematologica. 144(6). 627–632. 4 indexed citations

Hungria, Vânia, et al.. (2021). P-117: Multiple Myeloma treatment patterns and outcomes in the public and private healthcare systems in Brazil: one country, two worlds. Clinical Lymphoma Myeloma & Leukemia. 21. S98–S99.

10.

Façon, Thierry, Philippe Moreau, Thomas Martin, et al.. (2021). Isatuximab plus carfilzomib and dexamethasone versus carfilzomib and dexamethasone in elderly patients with relapsed multiple myeloma: IKEMA subgroup analysis.. Journal of Clinical Oncology. 39(15_suppl). 8026–8026. 7 indexed citations

11.

Villar, Rosângela Correa, et al.. (2020). Impact of bone events on survival in solitary bone plasmacytoma. Reports of Practical Oncology & Radiotherapy. 25(3). 389–395.

12.

Hungria, Vânia, Márcia Garnica, Edvan de Queiroz Crusoé, et al.. (2020). Managing patients with multiple myeloma during the COVID-19 pandemic: recommendations from an expert panel – ABHH monoclonal gammopathies committe. Hematology Transfusion and Cell Therapy. 42(3). 200–205. 6 indexed citations

13.

Martínez, Gracia, et al.. (2020). DESAFIOS NO DIAGNÓSTICO E TRATAMENTO DA CRIOGLOBULINEMIA TIPO I COM EVOLUÇÃO PARA GAMOPATIA MONOCLONAL DE SIGNIFICADO RENAL: RELATO DE CASO. Hematology Transfusion and Cell Therapy. 42. 256–256.

14.

Hungria, Vânia, Jae Hoon Lee, Ângelo Maiolino, et al.. (2019). Survival differences in multiple myeloma in Latin America and Asia: a comparison involving 3664 patients from regional registries. Annals of Hematology. 98(4). 941–949. 15 indexed citations

15.

Crusoé, Edvan de Queiroz, et al.. (2016). Is it feasible to use granulocyte-colony stimulating factor alone to mobilize progenitor cells in multiple myeloma patients induced with a cyclophosphamide, thalidomide and dexamethasone regimen?. Revista Brasileira de Hematologia e Hemoterapia. 38(4). 302–309. 3 indexed citations

16.

Pracchia, Luís Fernando, et al.. (2014). Prognostic Factors in Adolescent and Adult Patients With Acute Lymphoblastic Leukemia With Two Protocols of Chemotherapy: A Cross-Sectional Study. Clinical Lymphoma Myeloma & Leukemia. 15(1). e7–e14. 10 indexed citations

17.

Linardi, Camila C.G., Gracia Martínez, Elvira Deolinda Rodrigues Pereira Velloso, et al.. (2012). Evaluation of chromosomal abnormalities by cIg-FISH and association with proliferative and apoptotic indexes in multiple myeloma. Brazilian Journal of Medical and Biological Research. 45(11). 1074–1079. 5 indexed citations

18.

Maria, Durvanei Augusto, Martin Metzger, Camila C.G. Linardi, et al.. (2008). Thalidomide treatment down-regulates SDF-1α and CXCR4 expression in multiple myeloma patients. Leukemia Research. 33(7). 970–973. 29 indexed citations

19.

Martínez, Gracia. (2007). Fatores prognósticos no Mieloma Múltiplo. Revista Brasileira de Hematologia e Hemoterapia. 29(1). 1 indexed citations

20.

Sáez-Royuela, F., Juan Carlos Porres, Alberto Moreno, et al.. (1991). High doses of recombinant α-interferon or γ-interferon for chronic hepatitis C: A randomized, controlled trial. Hepatology. 13(2). 327–331. 92 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact